Cubist Systematic Strategies’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,400
Closed -$90.7K 3506
2025
Q1
$90.7K Sell
11,400
-39,200
-77% -$397K ﹤0.01% 2645
2024
Q4
$460K Sell
50,600
-93,600
-65% -$904K ﹤0.01% 2215
2024
Q3
$1.32M Buy
144,200
+86,200
+149% +$713K 0.01% 1666
2024
Q2
$567K Buy
58,000
+2,700
+5% +$32.9K ﹤0.01% 2066
2024
Q1
$835K Buy
55,300
+25,600
+86% +$465K ﹤0.01% 2296
2023
Q4
$640K Hold
29,700
﹤0.01% 2381
2023
Q3
$552K Buy
29,700
+11,800
+66% +$275K ﹤0.01% 2259
2023
Q2
$453K Buy
+17,900
New +$451K ﹤0.01% 2447

Other funds holding TDOC

Cubist Systematic Strategies's TDOC Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Teladoc Health (TDOC) stake by 99% in Q3 2025, selling an estimated $5.69M and leaving 7,760 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Cubist Systematic Strategies first reported a position in TDOC in Q3 2015 and has held it in 35 quarters since. The position peaked at $23.5M in Q3 2022. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Cubist Systematic Strategies held 7,760 shares of Teladoc Health worth $60K as of Q3 2025.
  • Cubist Systematic Strategies sold 728,921 Teladoc Health shares in Q3 2025, an estimated $5.69M.
  • Teladoc Health made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2835 holding.
  • Cubist Systematic Strategies first reported a position in Teladoc Health in Q3 2015 and has held it in 35 quarters since.
  • Cubist Systematic Strategies's Teladoc Health position peaked at $23.5M in Q3 2022.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.